Skip to content

HYPNOPS

Active Private limited company (pre-2019)founded 2000active for 26 yearsRue Pierre Thomé 56, 5020 NamurKBO/BCE: BE 0472.553.316

Lifetime

20 annual accounts with figures on one time axis, 25 filings since 2001
peak of €274,254 in 2025
€274,254▲ 7.5%
lowest -€27,375 in 2013
€186,087▲ 3.8%
peak of €797,811 in 2025
€797,811▲ 23.3%
€66,848▼ 36.3%
Board1 name since 2000
1 director
Documentsfilings and deeds
17-07-202614 days before the deadline
2025micro format
Dividend €35,300Equity from €647,024 to €797,811Debts from €104,982 to €66,848Investments €56,178Cash from €630,290 to €379,604

Key points

from the 2025 annual accounts

Equity

€797,811 ▲ 23.3%

HYPNOPS has made a profit without a break since 2015.

Turnover

≈ €410,000 estimated

The micro format states no turnover.

Investments

€56,178 6.3 times depreciation

Green is investment, beige is depreciation. Machinery stands 2553.9% higher than in 2024.

Liquidity

12.23 was 7.16 in 2024

Short-term debts fell from €104,948 to €66,848.

Filings

25 annual accounts since 2001
AprilJune31 JulyOctober20102020

The 2018 accounts came 12 days late. The other nine of the last ten were filed on time.

Position in the sector

€797,811

More equity than 90% of companies in human health. Sector median €125,088 · 21,349 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 20,149 companies had the same profile as HYPNOPS has now. Each dot stands for 51 companies, two years later.

95.0%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 20,149 companies, not a prediction for HYPNOPS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • deed of 02-12-2013
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0472553316
Legal-form change · Resignations & appointments Gazette deed
Capital decrease of €174,600 to €18,600 The capital fell from €193,200 to €18,600 · General meeting of 18-12-2017 · Gazette deed
Capital increase of €174,600 to €193,200 The capital rose from €18,600 to €193,200 · General meeting of 18-11-2013 · Gazette deed
All 36 events

Comparable companies

same main activity, similar in size and age
Company
HYPNOPS Namur €864,659 €274,254 92.3% -
HAMEROPHTA Rochefort €936,779 €303,741 89.1% -
Dr. F. DECLAU Hove €919,444 €263,825 80.9% -
DOKTER M. SCATORCHIA Maasmechelen €868,813 €285,884 96.5% -
DR. PETER PAREDIS Hasselt €911,798 €280,163 96.4% -
ORIANESTH Les Bons Villers €813,606 €290,936 44.3% -
DR. MARC DETOLLENAERE Koksijde €834,694 €297,691 89.3% -

These companies have the same main activity as HYPNOPS: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €814,000 and €937,000, founded between 1998 and 2001.

Official details

Source: KBO
Status
Active since 10-08-2000Normal situation
Activity
Specialist medical practiceNACE 86220
Financial year end
31 December
Peppol
Reachable since 14-02-2025
Company details

Annual accounts 2025

€864,659▲ 15.0%
Filing
Filed on 17-07-2026, 14 days before the end of the filing period
Financials

Insights on HYPNOPS

HYPNOPS files the micro format. That format states no turnover. The gross margin rose from €108,766 in 2006 to €274,254 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about HYPNOPS

What is the company number of HYPNOPS?
The company number of HYPNOPS is 0472.553.316. The VAT number is the same number with BE in front: BE 0472.553.316.
Where is HYPNOPS based?
The registered office is at Rue Pierre Thomé 56, 5020 Namur.Company details
What does HYPNOPS do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of HYPNOPS?
HYPNOPS is a private limited company (pre-2019) (BVBA).
When was HYPNOPS founded?
HYPNOPS was founded on 10-08-2000.
Is HYPNOPS still active?
Yes, HYPNOPS is an active enterprise in the KBO register.
What is the turnover of HYPNOPS?
The turnover in financial year 2025 is ≈ €410,000. This figure is estimated from the gross margin of €274,254 and 31 comparable companies (NACE 86220). It probably lies between €370,000 and €570,000.Financials
Is HYPNOPS profitable?
In financial year 2025, HYPNOPS made a profit of €186,087.
Where can I find the annual accounts of HYPNOPS?
HYPNOPS filed 25 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of HYPNOPS due?
HYPNOPS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.